MedTrace Logo

Project AMD: Comprehensive Characterisation of Age-Related Macular Degeneration and Its Progression

NCT04739319 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2024-02-09

No results posted yet for this study

Summary

Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss worldwide, and nearly two million Australians have some signs of AMD. This proposed project is a prospective, observational study that seeks to to understand the underlying aetiology of AMD, factors associated with differences between age-related macular degeneration (AMD) phenotypes or severities, or between AMD and healthy individuals. It also seeks to understand the natural history of AMD progression and the factors associated with the rate of progression. In this project, the disease phenotype, genotype and severity and rate of progression will be determined based on non-invasive clinical imaging or functional assessment of the retina, from obtaining biological samples from the participants, or from patient-reported outcomes.

Conditions

Interventions

OTHER

N/A Observational study

N/A Observational study

Sponsors & Collaborators

  • Center for Eye Research Australia

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-02
Primary Completion
2040-11-30
Completion
2040-11-30

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04739319 on ClinicalTrials.gov